BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23182919)

  • 1. Relationship of biochemically persistent disease and thyroglobulin-doubling time to age at surgery in patients with papillary thyroid carcinoma.
    Miyauchi A; Kudo T; Kihara M; Higashiyama T; Ito Y; Kobayashi K; Miya A
    Endocr J; 2013; 60(4):415-21. PubMed ID: 23182919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
    Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
    Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undetectable serum thyroglobulin levels in patients with medullary thyroid carcinoma after total thyroidectomy without radioiodine ablation.
    Tomoda C; Miyauchi A
    Thyroid; 2012 Jul; 22(7):680-2. PubMed ID: 22663550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
    Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
    Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation.
    Mourão GF; Rosario PW; Calsolari MR
    Endocr Relat Cancer; 2016 Jan; 23(1):47-52. PubMed ID: 26503963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?
    Wong H; Wong KP; Yau T; Tang V; Leung R; Chiu J; Lang BH
    Ann Surg Oncol; 2012 Oct; 19(11):3479-85. PubMed ID: 22576067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
    O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
    ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation.
    Park DJ; Lim JA; Kim TH; Choi HS; Ahn HY; Lee EK; Lee YJ; Kim KW; Park YJ; Yi KH; Cho BY
    Endocr J; 2012; 59(11):1021-30. PubMed ID: 22814366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.
    Miah CF; Zaman JA; Simon M; Davidov T; Trooskin SZ
    Surgery; 2014 Dec; 156(6):1491-6; discussion 1496-7. PubMed ID: 25456939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
    Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension.
    Jung SP; Kim M; Choe JH; Kim JS; Nam SJ; Kim JH
    World J Surg; 2013 Jul; 37(7):1606-13. PubMed ID: 23584460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of patients with low-risk papillary thyroid carcinoma and undetectable basal serum thyroglobulin after ablation measured with a sensitive assay: a prospective study.
    Rosario PW; dos Santos JB; Calsolari MR
    Horm Metab Res; 2013 Nov; 45(12):911-4. PubMed ID: 23757117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel Lymph Node Biopsy Status Correlates with Postoperative Stimulated Thyroglobulin Levels in Low-risk Papillary Thyroid Cancer Patients.
    Saliba J; Payne RJ; Varshney R; Sela E; Maniakas A; Rahme E; Mlynarek A; Caglar D; Hier MP; Tamilia M
    Endocr Pract; 2014 May; 20(5):399-404. PubMed ID: 24325994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low.
    Rosario PW; Furtado Mde S; Mourão GF; Calsolari MR
    Thyroid; 2015 Nov; 25(11):1243-8. PubMed ID: 26359309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive video-assisted thyroidectomy for papillary thyroid cancer: a prospective 5-year follow-up study.
    Del Rio P; Maestroni U; Sianesi M; Viani L; Vicente D; Stojadinovic A; Avital I
    Tumori; 2015; 101(2):144-7. PubMed ID: 25791536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.